Advocacy intelligence hub — real-time data for patient organizations
Assiut University
University of Alabama at Birmingham — PHASE4
Uludag University
Michelle Baczynski — NA
University of Melbourne — NA
Tufts Medical Center — NA
McGill University Health Centre/Research Institute of the McGill University Health Centre
Pontificia Universidad Catolica de Chile — NA
Nishtar Medical University — PHASE1
University of California, Irvine — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Cafcit
(Caffeine)Orphan drugO.P.R. Development, L.P.
Mechanism of Action Caffeine is structurally related to other methylxanthines, theophylline, and theobromine. It is a bronchial smooth muscle relaxant...
Namasivayam Ambalavanan, MD, M.D
University of Alabama at Birmingham
📍 BIRMINGHAM, AL
Diane Moddemann, MD
University of Manitoba, Winnipeg, Canada
Win Tin, MD
James Cook University Hospital, Middlesbrough, UK
Robin S Roberts, MTech
McMaster University
Alfonso Solimano, MD
Children & Women's Health Centre of BC, Vancouver, Canada
Arne Ohlsson, MD
Mount Sinai Hospital, Canada